Screener
Gyre Therapeutics, Inc. GYRE Sales & Marketing
Sales & Marketing at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | Gyre Pharmaceuticals | Gyre | Total |
|---|---|---|---|
| Revenues | $29,097 | $8 | $29,105 |
| Operating expenses | |||
| Cost of revenues | 2,209 | — | 2,209 |
| Selling and marketing | 13,754 | — | 13,754 |
| Research and development | 9,697 | 4,603 | 14,300 |
| Research and development - related parties | 4,836 | — | 4,836 |
| General and administrative | 4,268 | 3,594 | 7,862 |
| Transaction costs | — | 502 | 502 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s sales & marketing?
- Gyre Therapeutics, Inc. (GYRE) reported sales & marketing of $13.75M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s sales & marketing changed year-over-year?
- Gyre Therapeutics, Inc.'s sales & marketing decreased by 9.5% year-over-year, from $15.2M to $13.75M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s sales & marketing?
- Over 3 years (2022 to 2025), Gyre Therapeutics, Inc.'s sales & marketing has grown at a 6.3% compound annual growth rate (CAGR), from $54.24M to $65.18M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.
Ask your AI about Gyre Therapeutics, Inc.'s sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude